Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon alfa-associated retinopathy

R B Chambers1, A Downie, B Foote

  • 1William H. Havener Eye Center, Ohio State University, Columbus, USA.

The Journal of the American Osteopathic Association
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mapping palliative and end of care research in Australia (2000-2018).

Palliative & supportive care·2020
Same author

Trajectories of femorotibial cartilage thickness among persons with or at risk of knee osteoarthritis: development of a prediction model to identify progressors.

Osteoarthritis and cartilage·2018
Same author

Lack of effect of a topical regenerative agent on re-epithelialization rate of canine spontaneous chronic corneal epithelial defects: A randomized, double-masked, placebo-controlled study.

Veterinary journal (London, England : 1997)·2018
Same author

A unique case of acute embolus in a renal transplant with salvage by catheter-directed thrombolysis.

Scottish medical journal·2016
Same author

Response to: Letter to the Editor Regarding: The Expanding Phenotype of MELAS Caused by the m.3291 T > C tRNA Mutation E Kelland, C. A. Rupar, Asuri N. Prasad, K. Y. Tay, A. Downie and C. Prasad (1) by Josef Finsterer, MD, PhD [1], Sinda Zarrouk-Mahjoub, PhD [2] [1] Krankenanstalt Rudolfstiftung, Vienna [2] Genomics Platform, Pasteur Institute of Tunis, Tunisia.

Molecular genetics and metabolism reports·2016
Same author

The expanding phenotype of MELAS caused by the m.3291T > C mutation in the MT-TL1 gene.

Molecular genetics and metabolism reports·2016
Same journal

2020 AOA Research Abstracts and Poster Competition.

The Journal of the American Osteopathic Association·2020
Same journal

Communication Skills of Grandview/Southview Medical Center General Surgery Residents.

The Journal of the American Osteopathic Association·2020
Same journal

[PREPRINT] "Somebody Who Does Something Other Than Osteopathy".

The Journal of the American Osteopathic Association·2020
Same journal

Toward Resilience: Medical Students' Perception of Social Support.

The Journal of the American Osteopathic Association·2020
Same journal

Comparison of State Medical Licensing Board Disclosures Regarding Resident Performance for United States Allopathic, Osteopathic, and Foreign Medical Graduates.

The Journal of the American Osteopathic Association·2020
Same journal

Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.

The Journal of the American Osteopathic Association·2020
See all related articles

Interferon alfa treatment for hepatitis B and C can cause interferon-related retinopathy, leading to acute vision loss. This condition may only be partially reversible, highlighting a significant side effect of this antiviral therapy.

Area of Science:

  • Ophthalmology
  • Hepatology
  • Pharmacology

Background:

  • Interferon alfa has a decade-long history in treating viral illnesses, cancers, and leukemia.
  • Expanding research and experimental protocols are increasing the use of interferon alfa.
  • Primary care physicians may encounter patients undergoing interferon therapy.

Observation:

  • A 43-year-old male patient developed interferon-related retinopathy.
  • The patient was undergoing experimental treatment for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection.
  • The retinopathy resulted in acute vision loss.

Findings:

  • Interferon alfa therapy led to the development of retinopathy.
  • The vision loss experienced by the patient was acute.

Related Experiment Videos

  • The visual impairment was only partially reversible.

    • Implications:

    • This case highlights a potential ocular side effect of interferon alfa treatment.
    • Awareness of interferon-related retinopathy is crucial for clinicians managing patients on this therapy.
    • Further research into managing and preventing this adverse event is warranted.